The online version of this article (doi:10.1186/s13024-017-0167-y) contains supplementary material, which is available to authorized users.
Previous studies regarding the lipid-cognition relation in older adults are limited and have generated mixed results. We thus examined whether higher blood cholesterol concentrations were associated with faster cognitive decline in a community-based longitudinal study of Chinese elderly.
The study included 1,159 Chinese adults aged over 60 years (women: 48.7%, mean age: 79.4 years), who were free of dementia, Parkinson disease and stroke at the baseline. Blood concentrations of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), were assessed at the baseline. Global cognitive functions were assessed using the Chinese Mini-Mental State Examination (MMSE) at in 2009, 2012 and 2014. Association between blood cholesterol and repeated cognitive function was analyzed with linear mixed models, adjusting for sociodemographic information, behavior and lifestyle, depression symptoms, physical examination, hypertension, and laboratory indexes.
Higher baseline TC and LDL-C concentrations were significantly associated with greater cognitive decline. Adjusted mean difference in cognitive decline rate, comparing two extreme quartiles, was 0.28 points (MMSE score) per year (95% confident interval (CI): -0.54,–0.02; P-trend = 0.005) for TC and 0.42 points per year (95% CI: -0.69, -0.16; P-trend = 0.006) for LDL-C. In a subgroup analysis, the associations between all lipids and cognitive decline appeared to be more pronounced among individuals aged 100 years or older (n = 90), relative to others.
Higher blood concentrations of TC and LDL-C in late-life were associated with faster global cognitive decline.
Association As. 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 2015;11(3):332–84. CrossRef
Bums M, Duff K. Cholesterol in Alzheimer's disease and tauopathy. Ann N Y Acad Sci. 2002;977:367–75. CrossRef
Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science (New York, NY). 2001;294(5545):1354–7. CrossRef
Gu QP, Paulose-Ram R, Burt VL, Kit BK. Prescription Cholesterol-lowering Medication Use in Adults Aged 40 and Over United States, 2003–2012. NCHS Data Brief. 2014;177:1–8.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934. CrossRefPubMed
Yang J, Chen T, Li W, Liu L, Teo K, Yusuf S, et al. Current Status of Medication Usage for Cardiovascular Disease and Hypertension in China (PURE-China Study). Circulation. 2012;126:A15144.
Salim Y, Shofiqul I, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378(9798):1231–43. CrossRef
Yin Z, Shi X, Kraus VB, Brasher MS, Chen H, Liu Y, et al. Gender-dependent association of body mass index and waist circumference with disability in the Chinese oldest old. Obesity (Silver Spring, Md). 2014;22(8):1918–25. CrossRef
Zeng Y, Vaupel JW. Functional capacity and self-evaluation of health and life of oldest old in China. J Soc ssues. 2002;58(4):733–48. CrossRef
- Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly
- BioMed Central